Interesting that they have gone for capsules, makes sense to me as the dosage can be much more controlled. Given that DVT is a concern for frequent travellers they should be getting attention in the travel industry.
Trades and volumes looking sus again, the period since the double PME has made little sense IMHO. MM's are in charge again by the looks of it, the million buys may have finished.
Another product that has been developed for retail and airlines is called FlyFit Flow and this is being made available in capsule/supplement format and as an beverage.
Describing the claimed health benefits, the company said: “The drink helps to support a healthy blood flow for up to 18 hours and is 100% natural. The drink is a breakthrough beverage and helps to protect from DVT, which is a hot item in airline industry."
Confex is a unique trading group that negotiates in a wider range of product categories than any other trading group and offers 40 years of trading experience.
Confex is a privately-owned company with a reputation built on high levels of service and trading expertise with a turnover in excess of £1.9bn. Confex is an associate member of The Landmark Group which adds to the strength of Confex and the overall package we can offer.
I think yesterday nobody commented because we couldn't make sense of the sp movement. There weren't a lot of sells, on the face of it there were more buys, and yet the sp was dropped after those buys. The buy posted after close at .7 appears to have been held back so that the Ask could close at .67, and the few sells were at .63. The whole period of movement has an odd look to it. Just an observation, if anyone can add factual explanation that would be good, but it just looks like MM's in control to me.
That's just one of many ways, and not necessarily the top one. Long haul fliers may need a couple of doses a few times a year, compare that to a daily dose and the volume difference is obvious. If we can add to the health claims, and the variety of brand offerings, the majority aimed at daily consumption, again the potential is obvious.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.